Questions We Should Be Asking About Bevacizumab for Cervical Cancer
May 15th 2015There is good evidence that angiogenesis plays a central role in cervical cancer pathogenesis, suggesting a strong rationale for adding anti-angiogenesis agents to chemotherapeutic agents for the treatment of this disease.